Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real‐world experience
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 60
(4)
◽
pp. 955-963
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 56
(11)
◽
pp. 3052-3057
◽